The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Compositions Comprising Botulinum Neurotoxin - EP2939688

The patent EP2939688 was granted to Ipsen Biopharm on Feb 20, 2019. The application was originally filed on Jul 6, 2005 under application number EP15000178A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2939688

IPSEN BIOPHARM
Application Number
EP15000178A
Filing Date
Jul 6, 2005
Status
Opposition Rejected
Apr 21, 2023
Publication Date
Feb 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALLERGANNov 20, 2019HOFFMANN EITLE -

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2003138437
EXAMINATIONUS2003224020
EXAMINATIONWO9407510
OPPOSITIONDE10333317
OPPOSITIONEP1931306
OPPOSITIONUS2002107199
OPPOSITIONUS2003118598
OPPOSITIONUS2003138437
OPPOSITIONUS2003224020
OPPOSITIONUS2007134199
OPPOSITIONWO0137656
OPPOSITIONWO0158472
OPPOSITIONWO2005007185
OPPOSITIONWO9611699
OTHEREP1817051
OTHERUS2002064536
OTHERUS2003118598
OTHERUS4457916
OTHERUS5733873
OTHERUS9125804
OTHERWO0158472
SEARCHUS2003118598
SEARCHUS2004033241
SEARCHWO2004006954
SEARCHWO2004043430
SEARCHWO2006013357
SEARCHWO2006013370

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents